Clinical Trial Update: Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial update shows safety and tolerability data for M254 in healthy volunteers and patients with Immune Thrombocytopenic Purpura (ITP);…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenic Purpura

Drugs mentioned

• M254

Snippet

Sponsor: Momenta Pharmaceuticals, Inc. | Conditions: Immune Thrombocytopenic Purpura (ITP) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-07-01